Spots Global Cancer Trial Database for thymalfasin
Every month we try and update this database with for thymalfasin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Abscopal Effect for Metastatic Small Cell Lung Cancer | NCT02542137 | Small Cell Lung... Radiotherapy Thymalfasin | Radiotherapy Thymalfasin | 19 Years - | Zhejiang Provincial People's Hospital | |
Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type | NCT02906150 | Non-Small Cell ... | Thymalfasin (Th... SoC (chemothera... | 18 Years - | SciClone Pharmaceuticals | |
Abscopal Effect for Metastatic Non-small Cell Lung Cancer. | NCT02542930 | Non-small Cell ... Metastatic Non-... Radiotherapy Thymalfasin | Radiotherapy Thymalfasin | 19 Years - | Zhejiang Provincial People's Hospital | |
Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type | NCT02906150 | Non-Small Cell ... | Thymalfasin (Th... SoC (chemothera... | 18 Years - | SciClone Pharmaceuticals | |
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer | NCT06024356 | Colorectal Neop... | Thymalfasin | 18 Years - | Beijing Friendship Hospital | |
Abscopal Effect for Metastatic Non-small Cell Lung Cancer. | NCT02542930 | Non-small Cell ... Metastatic Non-... Radiotherapy Thymalfasin | Radiotherapy Thymalfasin | 19 Years - | Zhejiang Provincial People's Hospital | |
SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer | NCT02545751 | Esophageal Canc... Metastatic Esop... Stereotactic Bo... Thymalfasin | Stereotactic Bo... Thymalfasin | 19 Years - | Hangzhou Cancer Hospital | |
Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type | NCT02906150 | Non-Small Cell ... | Thymalfasin (Th... SoC (chemothera... | 18 Years - | SciClone Pharmaceuticals | |
Thymosin Alpha 1 Plus Maintenance Therapy With the Standard of Care (SoC) in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR Wild Type | NCT02906150 | Non-Small Cell ... | Thymalfasin (Th... SoC (chemothera... | 18 Years - | SciClone Pharmaceuticals | |
Abscopal Effect for Metastatic Small Cell Lung Cancer | NCT02542137 | Small Cell Lung... Radiotherapy Thymalfasin | Radiotherapy Thymalfasin | 19 Years - | Zhejiang Provincial People's Hospital | |
Abscopal Effect for Metastatic Colorectal Cancer | NCT02535988 | Colorectal Canc... Metastatic Colo... Thymalfasin | Radiation thera... Thymalfasin | 19 Years - | Zhejiang Provincial People's Hospital | |
Thymalfasin Adjuvant Therapy in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) After Curative Resection | NCT02281266 | Curable Hepatit... | curative resect... thymalfasin nucleoside anal... | 18 Years - 70 Years | Fudan University |